Manali Kamdar

14PUBLICATIONS

163CO-AUTHORS

Applied statisticsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 04, 2026

Five-year survival outcomes from TRANSCEND NHL 001 of lisocabtagene maraleucel in R/R LBCL.

|Apr 27, 2026

Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.

|Mar 23, 2026

From breakthroughs to blueprints: evolving evidence and future directions in relapsed and refractory large B-cell lymphoma.

Manali Kamdar, Nancy L Bartlett

|Feb 26, 2026

Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.

John Sharp, Paolo Strati, Subodh Bhatta

|Feb 24, 2026

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Yucai Wang, Melissa C Larson, Steven R Hwang

|Feb 18, 2026

Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM.

Manali Kamdar, Scott R Solomon, Jon E Arnason

Pageof 3

Frequent Collaborators

Jeremy S Abramson

Yucai Wang

Reem Karmali

Natalie S Grover

Narendranath Epperla

Steven R Hwang

Anita Kumar

Taylor R Brooks

David A Bond

Christine E Ryan

Frequent Collaborators

Jeremy S Abramson

Yucai Wang

Reem Karmali

Natalie S Grover